CHINATRIALS 2010 Advisory Board
 James Cai, Ph.D. Vice President, Clinical Development ATYR PHARMA |
 Ruiping Dong, M.D., Ph.D. Vice President, Global Development & Medical Affairs BRISTOL-MYERS SQUIBB |
 Frank Fan, M.D., MBA Medical Director WYETH |
 |
||
 James Garner, M.D. Vice President & General Manager TAKEDA CLINICAL RESEARCH |
 Min Irwin, M.D., Ph.D. Medical Director of BSP BAYER HEALTHCARE |
 Frank Jiang, M.D., Ph.D. Vice President, Global R&D/Head, China R&D SANOFI-AVENTIS |
|
||
 Simon Li, M.D., Ph.D Global Clinical Leader, PC BAYER HEALTHCARE |
 Zili Li, M.D., MPH Medical Director MSD CHINA |
 Bradley Marchant, M.D. Executive Director Head of Clinical Medicine Asia PFIZER CHINA R&D CENTER |
|
||
 Jay Mei, M.D., Ph.D. Executive Director, Clinical Development CELGENE |
 Ding Ming, Ph.D. Senior Director, CHC Medicine BOEHRINGER-INGELHEIM |
 Fidela Moreno, M.D. Vice President, Global Development Operations - Clinical Monitoring ALLERGAN |
|
||
 Bin Peng, M.D., Ph.D. Senior Director, Clinical Program Leader/Head of Oncology Translation Medicine, China NOVARTIS |
 Frank Shen, Ph.D. Asia Pacific Head of GPD Biometrics ROCHE PHARMA DEVELOPMENT CENTER |
 Jingsong Wang, M.D. Director Discovery Medicine & Clinical Pharmacology BRISTOL-MYERS SQUIBB |
|
||
 William Wang, Ph.D. Head, Asia Pacific Operations, BARDS MERCK & CO. |
 Li Yan, M.D., Ph.D. Director, Clinical Oncology MERCK & CO. |
 Songlin Xue, M.D., Ph.D Vice President & Global Head, Clinical Epidemiology NOVARTIS |
|
||
 Sherry Zhao, Ph.D. Manager, Biostatistics ROCHE PHARMA DEVELOPMENT CENTER |
||
 |
|
|
 |
About Your Organizer Jon E. Liong, Managing Partner, LYCHEE GROUP |